307 related articles for article (PubMed ID: 15865813)
21. How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Kabil Kucur S; Gozukara I; Aksoy A; Uludag EU; Keskin H; Kamalak Z; Carlioglu A
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):862-5. PubMed ID: 25402193
[TBL] [Abstract][Full Text] [Related]
22. Diane 35 and spironolactone combination in the treatment of hirsutism.
Kelestimur F
Clin Endocrinol (Oxf); 2001 May; 54(5):699-700. PubMed ID: 11380503
[No Abstract] [Full Text] [Related]
23. How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
Diamanti-Kandarakis E
J Endocrinol Invest; 1998 Oct; 21(9):623-9. PubMed ID: 9856417
[No Abstract] [Full Text] [Related]
24. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
Harborne L; Fleming R; Lyall H; Sattar N; Norman J
J Clin Endocrinol Metab; 2003 Sep; 88(9):4116-23. PubMed ID: 12970273
[TBL] [Abstract][Full Text] [Related]
25. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z
Br J Dermatol; 2016 Jul; 175(1):45-61. PubMed ID: 26892495
[TBL] [Abstract][Full Text] [Related]
26. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
Pedersen IM; Nielsen DR; Larsen J; Starup J
Ugeskr Laeger; 1985 Aug; 147(33):2594-6. PubMed ID: 2933858
[No Abstract] [Full Text] [Related]
27. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Buzney E; Sheu J; Buzney C; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Inal MM; Yildirim Y; Taner CE
Fertil Steril; 2005 Dec; 84(6):1693-7. PubMed ID: 16359967
[TBL] [Abstract][Full Text] [Related]
29. [Therapy of female hirsutism: current status and new findings].
De Pedrini P; Suraci C; Costa C
Clin Ter; 1983 Mar; 104(6):447-55. PubMed ID: 6221859
[No Abstract] [Full Text] [Related]
30. Hormonal therapy for acne: why not as first line therapy? facts and controversies.
Katsambas AD; Dessinioti C
Clin Dermatol; 2010; 28(1):17-23. PubMed ID: 20082945
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and treatment of hirsutism].
Ylöstalo P
Duodecim; 1984; 100(11):686-90. PubMed ID: 6468307
[No Abstract] [Full Text] [Related]
32. Cyproterone acetate for hirsutism.
Van der Spuy ZM; le Roux PA
Cochrane Database Syst Rev; 2003; 2003(4):CD001125. PubMed ID: 14583927
[TBL] [Abstract][Full Text] [Related]
33. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
[TBL] [Abstract][Full Text] [Related]
34. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Influence on androgens in the serum and urine and on urinary cortisol].
Nielsen DR; Larsen J; Pedersen IM; Starup J
Ugeskr Laeger; 1985 Aug; 147(33):2589-93. PubMed ID: 2933857
[No Abstract] [Full Text] [Related]
35. [Anti-androgenic steroid cyproterone acetate. Clinical pharmacology and therapeutic use in hirsutism and acne].
van Wayjen RG; van den Ende A
Ned Tijdschr Geneeskd; 1976 Jan; 120(5):189-95. PubMed ID: 129710
[No Abstract] [Full Text] [Related]
36. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Luboshitzky R; Herer P; Shen-Orr Z
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
[TBL] [Abstract][Full Text] [Related]
37. Assessment, diagnosis and treatment of a patient with hirsutism.
Yildiz BO
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):294-300. PubMed ID: 18332896
[TBL] [Abstract][Full Text] [Related]
38. The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
Gul OB; Somunkiran A; Yucel O; Demirci F; Ozdemir I
Arch Gynecol Obstet; 2008 Jan; 277(1):25-30. PubMed ID: 17618446
[TBL] [Abstract][Full Text] [Related]
39. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Luque-Ramírez M; Alvarez-Blasco F; Uriol Rivera MG; Escobar-Morreale HF
Hum Reprod; 2008 Jul; 23(7):1594-601. PubMed ID: 18375410
[TBL] [Abstract][Full Text] [Related]
40. Antiandrogens and hirsutism.
Biffignandi P; Molinatti GM
Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
